Abstract:
The identification of different Toll-like receptors (TLRs) and their associated ligand together with cytokine production and dendritic cell maturation following TLR engagement have facilitated vaccine research and formulation. In our study, we identified capsid protein VP3 of foot-and mouth disease virus activated TLR2. VP3 induced Bone marrow-derived dendritic cells maturation and cytokine production. Furthermore, VP3 fused with four tandem copies of ectodomain of the conserved influenza matrix protein M2 (VP3-4xM2e) is effective as an adjuvant against influenza virus. This is the first time that VP3 has been shown to activate TLR2. Other known TLR2 agonists are lipopeptides, glycoproteins, glycolipids, peptidoglycans and zymozan.
Fields of Application:
Vaccine adjuvant
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
IP Status:US 8795678 TW I 454478
